Articles, App Notes, Case Studies, & White Papers

31. Shorten Trial Timelines With Better Evidence Generation 8/2/2024

    Learn how digital data is helping the pharmaceutical industry tackle its most daunting challenge; the 12 year, $3 billion average to bring a new drug to market.

32. 3 Study Areas Where Your IRT Vendor Should Do More 11/21/2024

    Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.

33. The Benefits Of Next-Generation SAAS Have Arrived 11/7/2024

    See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

34. Wearables In Clinical Trials: Real Benefits Beyond The Hype 5/7/2024

    Gain insight into the slow adoption rates and consider several compelling reasons why researchers should integrate these devices sooner rather than later.

35. Automated Trial Monitoring Workflows Make A Lean Team More Efficient 1/7/2026

    A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.

36. RTSM Automating Adaptive Enrollment In Basket Trials 6/26/2026

    Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.

37. Reduce Workloads And Improve Insights With Crowdsource UAT 6/28/2023

    Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

38. One Day, We Won't Need Placebos 11/17/2023

    Embrace the future of clinical research by recognizing the limitations of traditional double-blind trials and exploring the transformative potential of real-world evidence (RWE).

39. Measuring The True Patient Experience 5/15/2024

    Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.

40. Clinical Trials In The Age Of Cost Caps 4/14/2025

    On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.